MTOR and graft versus host disease: Reduction in Tconv glycolytic activity via mTOR inhibition results in a more Treg-like metabolic profile, and this mTOR inhibition-mediated Tconv functional shift also prevented the induction of graft-versus-host disease (GvHD) (129).